- Home
- XPEV vs TECH Comparison
XPEV vs TECH Comparison
Compare XPEV & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPEV | TECH |
|---|---|---|
| Founded | 2015 | 1976 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 11.2B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | XPEV | TECH |
|---|---|---|
| Price | $11.87 | $72.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $23.08 | ★ $71.82 |
| AVG Volume (30 Days) | ★ 5.7M | 3.3M |
| Earning Date | 05-20-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | N/A | ★ $1,219,635,000.00 |
| Revenue This Year | $25.76 | $2.49 |
| Revenue Next Year | $25.98 | $6.40 |
| P/E Ratio | ★ N/A | $89.04 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $11.54 | $43.20 |
| 52 Week High | $28.20 | $72.39 |
Technical Indicators
Market Signals| Indicator | XPEV | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 36.34 | 70.52 |
| Support Level | $11.77 | $70.49 |
| Resistance Level | $13.34 | $72.22 |
| Average True Range (ATR) | 0.31 | 0.29 |
| MACD | -0.05 | -0.51 |
| Stochastic Oscillator | 14.21 | 59.88 |
Price Performance
Historical ComparisonAbout XPEV XPeng Inc.
Founded in 2015, XPeng is a leading Chinese smart electric vehicle company that designs, develops, manufactures, and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold about 430,000 EVs in 2025, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.